Cancer survivors face heart damage from life-saving treatments

In the United States, specifically in Colorado, a significant number of cancer survivors are facing unexpected health issues related to their past treatments. The advancements in oncology have allowed many patients to overcome cancer, but these survivors are now reporting heart-related complications, largely attributed to the adverse effects of chemotherapy, radiation, and immunotherapy. Dr. Ahmad Manshad, a prominent cardiologist associated with South Denver Cardiology and AdventHealth, has been vocal about the emergence of cardiotoxicity among these patients. He emphasizes that as patients continue to live longer post-cancer treatment, the risk of developing cardiovascular diseases increases. Currently, approximately 18 million individuals in the U.S. are living as cancer survivors, as noted by the American Cancer Society. This growing population has led to the development of the subspecialty known as cardio-oncology, which focuses specifically on the identification, monitoring, and treatment of cardiovascular conditions that arise from cancer therapies. Dr. Manshad practices in this field, with a clear mission to catch cardiac dysfunction in cancer survivors early, allowing for timely intervention and adjustments in treatment plans. Symptoms of cardiotoxicity can manifest as hypertension, coronary artery disease, and heart failure. Dr. Manshad advises any cancer survivors who experience shortness of breath, unusual fatigue, chest pain, or swelling in the legs to seek immediate evaluation from their primary care physician or oncologist. These warning signs could indicate severe cardiac complications that require prompt attention. Ultimately, the goal is to ensure that these patients not only survive their cancer but thrive in survivorship with healthy hearts. As awareness of this issue grows, it is imperative for both healthcare providers and survivors to prioritize heart health in their ongoing care plans.